These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 5605172)

  • 21. [Arteriosclerosis--nicotinic acid therapy. 2. Alterations in serum lipoproteins. Diagnosis, therapy].
    Gustafson A
    Lakartidningen; 1971 Apr; 68(15):1744-5 passim. PubMed ID: 5577244
    [No Abstract]   [Full Text] [Related]  

  • 22. Diet and drug therapy for hyperlipoproteinemia.
    Maha GE
    Med Times; 1971 Aug; 99(8):49-63 passim. PubMed ID: 5566828
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of dyslipemias with the association of dx-thyroxine and choleretics].
    Martinelli M; Albini U; Villecco A
    Boll Soc Ital Cardiol; 1970; 15(6):539-43. PubMed ID: 5517650
    [No Abstract]   [Full Text] [Related]  

  • 24. [Study of the therapeutic effects of disodium etidronate (EHDP) on hypercholesteremia and on hypertriglyceridemia].
    Gennari C; Picchi M; Pepi F
    Boll Soc Ital Cardiol; 1975; 20(10):1145-53. PubMed ID: 825131
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect on serum tocopherol levels of drug-induced decrease in serum lipids.
    Weiss P; Bianchine JR
    Am J Med Sci; 1969 Oct; 258(4):275-81. PubMed ID: 5823464
    [No Abstract]   [Full Text] [Related]  

  • 26. [New aspects of the therapy of arteriosclerosis].
    Avogaro P; Capri C; Cazzolato G
    Recenti Prog Med; 1971 Nov; 51(5):455-70. PubMed ID: 5172398
    [No Abstract]   [Full Text] [Related]  

  • 27. Hyperlipoproteinemias in the prematurely aged. Theories of pathogenesis, diagnosis, classification, and treatment.
    Herrmann GR
    Geriatrics; 1970 Apr; 25(4):103-14. PubMed ID: 5443794
    [No Abstract]   [Full Text] [Related]  

  • 28. [Classification of hyperlipoproteinemias and the problem of "atherogenicity"].
    Fasoli A
    G Ital Cardiol; 1971; 1(4):287-90. PubMed ID: 5126211
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical trial of tibric acid, a new hypolipidemic agent].
    Noseda G; Sirtori CR
    Schweiz Med Wochenschr; 1974 Dec; 104(51):1917-22. PubMed ID: 4438990
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical trials with Fonlipol. Apropos of 50 cases].
    Warembourg H; Jaillard J
    Lille Med; 1974 Apr; 19(4 Suppl 11):528-31. PubMed ID: 4612282
    [No Abstract]   [Full Text] [Related]  

  • 31. [The study of clofibrate. The viewpoint of Professor D. Kritchevsky interviewed by V. Fabbrocini].
    Kritchevsky D
    Minerva Med; 1979 Dec; 70(55):3808-9. PubMed ID: 523009
    [No Abstract]   [Full Text] [Related]  

  • 32. Sorting out the hyperlipidemias.
    Grundy SM
    Med Times; 1978 Apr; 106(4):36-41, 45. PubMed ID: 642746
    [No Abstract]   [Full Text] [Related]  

  • 33. [Activity of a phospholipid association on serum lipoproteins and on cholesteremia].
    Rossi F; Bordo D
    Minerva Med; 1967 Jul; 58(57):2608-16. PubMed ID: 6057206
    [No Abstract]   [Full Text] [Related]  

  • 34. Recommendations for treatment of hyperlipidemia in adults. A joint statement of the Nutrition Committee and the Council on Arteriosclerosis.
    Circulation; 1984 May; 69(5):1067A-1090A. PubMed ID: 6368042
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hyperlipemia].
    Lemaire A
    Presse Med (1893); 1970 Jul; 78(33):1467-9. PubMed ID: 5428992
    [No Abstract]   [Full Text] [Related]  

  • 36. Diagnosis and treatment of Type II and Type IV hyperlipoproteinemia in the office practice setting.
    Millett F; Sielski J; Stoll H; Alston N; Gail S
    PA J; 1976; 6(2):54-9. PubMed ID: 10235781
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hypocholestermic agents in therapy].
    Grossi F; Palleschi M
    Clin Ter; 1966 Oct; 39(1):65-77. PubMed ID: 5998858
    [No Abstract]   [Full Text] [Related]  

  • 38. [Classification of dyslipidemias].
    Spigai C
    G Gerontol; 1972 Apr; 20(4):305-16. PubMed ID: 5042386
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effects of glucuronyl-glucosamino-glycan sulfate in a group of patients with blood lipid disorders].
    Cossu G
    Clin Ter; 1979 Jan; 88(2):173-81. PubMed ID: 428197
    [No Abstract]   [Full Text] [Related]  

  • 40. Elevated remnant-like particle cholesterol concentration: a characteristic feature of the atherogenic lipoprotein phenotype.
    Twickler TB; Dallinga-Thie GM; Cohn JS; Chapman MJ
    Circulation; 2004 Apr; 109(16):1918-25. PubMed ID: 15117861
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.